Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.78022 | 33 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.76207 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.76517 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.70651 | 33 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.67806 | 32 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.83986 | 33 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.03975 | 42 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.21756 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.69833 | 32 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.74906 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.74815 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.70339 | 32 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.8401 | 37 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.75605 | 34 |